News
Recent news about Panacea Capital and select portfolio companies
March 2, 2026
Interview with Peter Pang: Where Biosimilar CMC Risk Really Sits Today
March 2, 2026
Interview with Peter Pang: Where Biosimilar CMC Risk Really Sits Today
February 26, 2026
Podcast featuring Jean-Marie Cuillerot, Chief Medical Officer at Kainova Therapeutics – Closing the gap on rare diseases in 2026
February 26, 2026
Podcast featuring Jean-Marie Cuillerot, Chief Medical Officer at Kainova Therapeutics – Closing the gap on rare diseases in 2026
February 26, 2026
Evox Therapeutics Partners with Rett Syndrome Research Trust to Evaluate ExoEdit® Technology to Enable Gene Editing in Rett Syndrome
February 26, 2026